Amuthakannan Subramaniam

Title: Amuthakannan Subramaniam: Innovator in Fibroblast Growth Factor Therapeutics

Introduction

Amuthakannan Subramaniam is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents.

Latest Patents

He holds a patent for "Recombinant modified fibroblast growth factors and therapeutic uses thereof." This patent describes modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions, and medicaments that include such modified FGF polypeptides. The methods outlined in the patent focus on using these modified FGF polypeptides to treat or prevent conditions that benefit from the administration of FGFs. He has 1 patent to his name.

Career Highlights

Amuthakannan Subramaniam is currently associated with Trefoil Therapeutics, Inc., where he continues to advance his research and innovations in the field. His work is pivotal in developing new therapeutic strategies that leverage the properties of fibroblast growth factors.

Collaborations

He collaborates with esteemed colleagues, including David Eveleth and Jennifer Jenkins-Eveleth, who contribute to his research endeavors and the overall mission of Trefoil Therapeutics.

Conclusion

Amuthakannan Subramaniam is a key figure in the biotechnology sector, with a focus on fibroblast growth factors that hold promise for various therapeutic applications. His innovative work continues to impact the field positively.